Immunization by particle-mediated transfer of the granulocyte-macrophage colony-stimulating factor gene into autologous tumor cells in melanoma or sarcoma patients: Report of a phase I/IB study

Human Gene Therapy

Volumn 13, Issue 14, 2002, Pages 1711-1721

  Mahvi, David M ^a,b   Pharo, L ^b   Gan, J ^b   Heisey, D ^a   Warner, T ^a,b   Sondel, P M ^a,b   Shi, F S ^a   Yang, N S ^b   Weber, S ^a   Hank, J ^b   Albertini, M ^a,b   Schiller, J ^a,b   Schalch, H ^b   Larson, M ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR VACCINE;

ARTICLE; CANCER CELL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA TRANSFECTION; GENE TRANSFER; GENETIC TRANSFECTION; HISTOPATHOLOGY; HOST; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; IRRADIATION; LYMPHOCYTIC INFILTRATION; MELANOMA; PATIENT MONITORING; SARCOMA; TOXICITY; TREATMENT OUTCOME; TUMOR LOCALIZATION;

BIOLISTICS; BIOLOGICAL RESPONSE MODIFIERS; CANCER VACCINES; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEASIBILITY STUDIES; GOLD; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYPERSENSITIVITY, DELAYED; INJECTIONS, INTRADERMAL; LEIOMYOSARCOMA; LIPOSARCOMA; MELANOMA; SAFETY; SARCOMA; SOFT TISSUE NEOPLASMS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; VACCINES, DNA;

EID: 18644379386     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303402760293556     Document Type: Article

References (47)

1. Albertini, M.R., Emler, C.A., Schell, K., Tans, K.J., King, D.M., and Sheehy, M.J. (1996). Dual expression of human leukocyte antigen molecules and the B7-1 costimulatory molecule (CD80) on human melanoma cells after particle-mediated gene transfer. Cancer Gene Ther. 3, 192-201.
2. Balch, C.M., Houghton, A.N., and Peters, L.J. (1993). Cutaneous melanoma. In Cancer: Principles and Practice of Oncology. V.T. DeVita, S. Hellman, and S.A. Rosenberg, eds. (Lippincott, Philadelphia) pp. 1612-1661.
3. Berns, A.J., Clift, S., Cohen, L.K., Donehower, R.C., Dranoff, G., Hauda, K.M., Jaffee, E.M., Lazenby, A.J., Levitsky, H.I., and Marshall, F.F. (1995). Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma. Hum. Gene Ther. 6, 347-368.
4. Brichard, V., Van Pel, A., Wolfel, T., Wolfel, C., De Plaen, E., Lethe, B., Coulie, P., and Boon, T. (1993). The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178, 489-495.
5. Burkholder, J.K., Decker, J., and Yang, N. S. (1993). Rapid transgene expression in lymphocyte and macrophage primary cultures after particle bombardment-mediated gene transfer. J. Immunol. Methods 165, 149-156.
6. Cassileth, P.A., Podack, E., Sridhar, K., Savaraj, N., and Hanlon, J. (1995). Phase I study of transfected cancer cells expressing the interleukin-2 gene product in limited stage small cell lung cancer. Hum. Gene Ther. 6, 369-383.
7. Cheng, L., Ziegelhoffer, P.R., and Yang, N.S. (1993). In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc. Natl. Acad. Sci. U.S.A. 90, 4455-4459.
8. Colombo, M.P., Modesti, A., Parmiani, G., and Forni, G. (1992). Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res. 52, 4853-4857.
9. Crowley, N.J., and Seigler, H.F. (1993). Possibilities of immunotherapy and gene therapy for malignant melanoma. Semin. Surg. Oncol. 9, 273-278.
10. Dranoff, G. (1999). Interpreting cancer vaccine clinical trials. J. Gene Med. 1, 80-83.
11. Dranoff, G., and Mulligan, R.C. (1995). Gene transfer as cancer therapy. Adv. Immunol. 58, 417-454.
12. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. U.S.A. 90, 3539-3543.
13. Ezzell, C. (1995). Cancer "vaccines": An idea whose time has come? J. NIH Res. 7, 46-49.
14. Freeman, S.M., Mccune, C., Robinson, W., Abboud, C.N., Abraham, G.N., Angel, C., and Marrogi, A. (1995). The treatment of ovarian cancer with a gene modified cancer vaccine: A phase I study. Hum. Gene Ther. 6, 927-939.
15. Grabstein, K.H., Urdal, D.L., Tushinski, R.J., Mochizuki, D.Y., Price, V.L., Cantrell, M.A., Gillis, S., and Conlon, P.J. (1986). Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 232, 506-508.
16. Hellman, S. (1994). Immunotherapy for metastatic cancer: Establishing a "proof of principle." JAMA 271, 945-946.
17. Herrmann, F. (1995). Cancer gene therapy: Principles, problems, and perspectives. J. Mol. Med. 73, 157-163.
18. Jaffee, E.M., Abrams, R., Cameron, J., Donehower, R., Duerr, M., Gossett, J., Greten, T.F., Grochow, L., Hruban, R., Kern, S., Lillemoe, K.D., O'Reilly, S., Pardoll, D., Pitt, H.A., Sauter, P., Weber, C., and Yeo, C. (1998). A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma. Hum. Gene Ther. 9, 1951-1971.
19. Kawakami, Y., Eliyahu, S., Delgado, C.H., Robbins, P.F. Rivoltini, L., Topalian, S.L., Miki, T., and Rosenberg, S.A. (1994a). Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. U.S.A. 91, 3515-3519.
20. Kawakami, Y., Eliyahu, S., Delgado, C.H., Robbins, P.F., Sakaguchi, K., Appella, E., Yannelli, J.R., Adema, G.J., Miki, T., and Rosenberg, S.A. (1994b). Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. U.S.A. 91, 6458-6462.
21. Kleinerman, E.S., Knowles, R.D., Lachman, L.B., and Gutterman, J.U. (1988). Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration. Cancer Res. 48, 2604-2609.
22. Leong, S.P., Enders-Zohr, P., Zhou, Y.M., Stuntebeck, S., Habib, F.A., Allen, R.E., Jr., Sagebiel, R.W., Glassberg, A.B., Lowenberg, D.W., and Hayes, F.A. (1999). Recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic melanoma. J. Immunother. 22, 166-174.
23. Mackiewicz, A., Gorny, A., Laciak, M., Malicki, J., Murawa, P., Nowak, J., Wiznerowicz, M., Hawley, R.G., Heinrich, P.C., and Rose-John, S. (1995). Gene therapy of human melanoma: Immunization of patients with autologous tumor cells admixed with allogeneic melanoma cells secreting interleukin 6 and soluble interleukin 6 receptor. Hum. Gene Ther. 6, 805-811.
24. Mahvi, D.M., Burkholder, J.K., Turner, J., Culp, J., Malter, J.S., Sondel, P.M., and Yang, N.S. (1996). Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: Implications for a clinically relevant tumor vaccine. Hum. Gene Ther. 7, 1535-1543.
25. Mahvi, D.M., Sondel, P.M., Yang, N.S., Albertini, M.R., Schiller, J.H., Hank, J., Heiner, J., Gan, J., Swain, W., and Logrono, R. (1997). Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma. Hum. Gene Ther. 8, 875-891.
26. Mastrangelo, M.J., Maguire, H.C. Jr., Eisenlohr, L.C., Lughlin, C.E., Monken, C.E., Mccue, P.A., Kovatich, A.J., and Lattime, E.C. (1999). Intratumoral recombinant GM-CSF-encoding virus a gene therapy in patients with cutaneous melanoma. Cancer Gene Ther. 6, 409-422.
27. Mcallister, H.A., Jr. (1995). Endomyocardial biopsy in the evaluation of conditions leading to cardiac transplantation and in the evaluation of cardiac allograft rejection. Texas Heart Inst. J. 22, 53-66.
28. Mccabe, D.E., and Martinell, B.J., inventors. Agracetus, assignee: Apparatus for genetic transformation. U.S. Patent 5149655. September 22, 1992.
29. Mccabe, D.E., Swain, W.F., Martinell, B.J., and Christou, P. (1988). Stable transformation of soybean (Glycine max) by particle acceleration. Biotechnology 6, 923-926.
30. Metcalf, D. (1986). The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood 67, 257-267.
31. Morrissey, P.J., Bressler, L., Charrier, K., and Alpert, A. (1988). Response of resident murine peritoneal macrophages to in vivo administration of granulocyte-macrophage colony-stimulating factor. J. Immunol. 140, 1910-1915.
32. Nelson, W.G, Simons, J.W., Mikhak, B., Chang, J.F., Demarzo, A.M., Carducci, M.A., Kim, M., Weber, C.E., Baccala, A.A., Goeman, M.A., Clift, S.M., Ando, D.G., Levitsky, H.I., Cohen, L.K., Sanda, M.G., Mulligan, R..C., Partin, A.W., Carter, H.B., Piantadosi, S., and Marshall, F.F. (2000). Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies. Cancer Chemother. Pharmacol. 46(Suppl.), S67-S72.
33. Plautz, G.E., Yang, Z.Y., Wu, B.Y., Gao, X., Huang, L., and Nabel, G.J. (1993). Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc. Natl. Acad. Sci. U.S.A. 90, 4645-4649.
34. Rini, B.I., Stadler, W.M., Spielberger, R.T., Ratain, M.J., and Vogelzang, N.J. (1998). Granulocyte-macrophage colony stimulating factor in metastatic renal cell carcinoma: A phase II trial. Cancer 82, 1352-1358.
35. Rosenberg, S.A., Yang, J.C., Topalian, S.L., Schwartzentruber, D.J., Weber, J.S., Parkinson, D.R., Seipp, C.A., Einhorn, J.H., and White, D.E. (1994). Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 271, 907-913.
36. Scheibenbogen, C., Schmittel, A., Keilholz, U., Allgauer, T., Hofmann, U., Max, R., Thiel, E., and Schadendorf, D. (2000). Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma. J. Immunother. 23, 275-281.
37. Shi, F.S., Weber, S., Gan, J., Rakhmilevich, A.L., and Mahvi, D.M. (1999). Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF. Cancer Gene Ther. 6, 81-88.
38. Simmons, S.J., Tjoa, B.A., Rogers, M., Elgamal, A., Kenny, G.M., Ragde, H., Troychak, M.J., Boynton, A.L., and Murphy G.P. (1999). GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial. Prostate 39, 291-297.
39. Simons, J.W., Mikhak, B., Chang, J.F., Demarzo, A.M., Carucci, M.A., Lim, M., Weber, C.E., Baccala, A.A., Goemann, M.A., Clift, S.M., Ando, D.G., Levitsky, H.I., Cohen, L.K., Sanda, M.G., Mulligan, R.C., Partin, A.W., Carter, H.B., Piantadosi, S., Marshall, F.F., and Nelson, W.G. (1999). Induction of immunity to prostate cancer antigens; results of clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macr ophage colony-stimulating factor using ex vivo gene transfer. Cancer Res. 59, 5160-5168.
40. Soiffer, R., Lynch, T., Mihm, M., Jung, K., Rhuda, C., Schmollinger, J.C., Hodi, F.S., Liebster, L., Lam, P., Mentzer, S., Singer, S., Tanabe, K..K., Cosimi, A.B., Duda, R., Sober, A., Bhan, A., Daley, J., Neuberg, D., Parry, G., Rokovich, J., Richards, L., Drayer, J., Berns, A., Clift, S., Dranoff, G., et al. (1998). Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc. Natl. Acad. Sci. U.S.A. 95, 13141-13146.
41. Storm, F.K., and Mahvi, D.M. (1991). Diagnosis and management of retroperitoneal soft-tissue sarcoma. Ann. Surg. 214, 2-10.
42. Sun, W.H., Burkholder, J.K., Sun, J., Culp, J., Turner, J., Lu, X.G., Pugh, T.D., Ershler, W.B., and Yang, N.S. (1995). In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc. Natl. Acad. Sci. U.S.A. 92, 2889-2893.
43. Thomassen, M.J., Ahmad, M., Barna, B.P., Antal, J., Wiedemann, H.P., Meeker, D.P., Klein, J., Bauer, L., Gibson, V., Andresen, S., et al. (1991). Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapy. Cancer Res. 51, 857-862.
44. Thompson, T.A., Gould, M.N., Burkholder, J.K., and Yang, N.S. (1993). Transient promoter activity in primary rat mammary epithelial cells evaluated using particle bombardment gene transfer. In Vitro Cell Dev. Biol. 29A, 165-170.
45. Yang, N.S., and Sun, W.H. (1995). Gene gun and other non-viral approaches for cancer gene therapy. Nat. Med. 1, 481-483.
46. Yang, N.S., Burkholder, J., Roberts, B., Martinell, B., and Mccabe, D. (1990). In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. U.S.A. 87, 9568-9572.
47. Zalupski, M.M., Ryan, J.R., Hussein, M.E., and Baker, L.H. (1993). Systemic adjuvant chemotherapy for soft tissue sarcomas of the extremities. Surg. Oncol. Clin. N. Am. 2, 621-637.